OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Organization: University of Nevada Las Vegas

2 Projects | 1 Researchers | $3,397,762 Invested

2024

University of Nevada Las Vegas

Jeffrey Cummings, MD

Alzheimer's Disease Biomarker Observatory (BMO): Biomarker Data Capture, Curation, and Provision of Access

  • Funding Amount: $3,247,762
  • Organization Type: Academic/Nonprofit
  • Program: Biomarkers
  • Target: Other
  • Status: Active

2019

University of Nevada Las Vegas

Jeffrey Cummings, MD

2019 Annual Goodes Prize for Excellence in Alzheimer’s Drug Discovery: Rasagiline Rescue in Alzheimer’s Disease Clinical Trial (R2 Trial) – Biomarker add-on funding

  • Funding Amount: $150,000
  • Organization Type: Academic/Nonprofit
  • Program: Clinical
  • Target: Synaptic Activity and Neurotransmitters
  • Status: Active